United States
Germany
Japan
United Kingdom
China
POLA2 mouse monoclonal antibody, clone OTI2B4 (formerly 2B4)
| Applications | WB |
| Reactivities | Human |
Products
POLA2 mouse monoclonal antibody, clone OTI3F2 (formerly 3F2)
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3F2 (formerly 3F2), Biotinylated
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7), Biotinylated
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI2B4 (formerly 2B4), Biotinylated
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3F2 (formerly 3F2), HRP conjugated
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7), HRP conjugated
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI2B4 (formerly 2B4), HRP conjugated
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) POLA2 mouse monoclonal antibody, clone OTI2B4 (formerly 2B4)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) POLA2 mouse monoclonal antibody, clone OTI3F2 (formerly 3F2)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) POLA2 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI2B4 (formerly 2B4)
| Applications | WB |
| Reactivities | Human |
POLA2 mouse monoclonal antibody, clone OTI3F2 (formerly 3F2)
| Applications | WB |
| Reactivities | Human |
